Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to help treat people who have had adverse reactions to antidepressant medication including to (a) selective serotonin reuptake inhibitors and (b) serotonin and norepinephrine reuptake inhibitors.

The Medicines and Healthcare products Regulatory Agency approved Patient Information Leaflets outline the details of possible adverse reactions associated with selective serotonin reuptake inhibitors and serotonin and norepinephrine reuptake inhibitors, and highlight when the advice of a healthcare professional should be sought for specific serious adverse reactions.

People who are concerned about adverse reactions to antidepressants should speak to a healthcare professional. Suspected adverse reactions to medicines, including antidepressant medication, can be reported through the Yellow Card Scheme, which is the system for recording adverse reactions suspected to be associated with medicines and medical devices in the United Kingdom.